av/entera-bio--big.svg

NASDAQ:ENTX

Entera Bio Ltd.

Add to Watchlist
  • Stock

2.23

+2.76%

0.35

USD last updated 11/08 02:03:55

Last Close

1.88

11/08 20:00

Market Cap

64.47M

Beta: 1.84

Volume Today

13.71K

Avg: 246.50K

PE Ratio

−3.78

PFCF: −3.20

OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed Phase II clinical trials for the ...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -0.4-0.3-0.2-0.10.10.22019-03-282020-11-192022-05-122023-08-112024-09-12

    Revenue (Estimate*)

    100K200K300K400K500K2019-03-282020-11-192022-05-122023-08-112024-09-12

    *Estimate based on analyst consensus